To Deal With Volatility, Consider These 3 Options on the Risk Spectrum
They range from doing nothing to jumping into the day-trading fray.
Tilray Isn't Going to Get That High
TLRY posted promising earnings, but don't expect it smoke past its current levels for long.
I Wouldn't Jump on the Tilray Bandwagon, But Here's What I Would Do
You think the Tilray brand name is worth $2.8B? Market cap is barely above $3B. Does give me pause.
I'm Treading Carefully Entering 2022 as Many Momentum Stocks Remain Bearish
Cannabis is about the only space where I'm long, and that isn't for technical reasons.
2021 Year in Review: A Very Good Market for Mega-Cap Stocks... But Not Much Else
The broader market had a very tough go of it in 2021, but you wouldn't know it unless you do some digging. From Reddit and Diamond Hands to SPACs and a stealth bear market, it's been a wild ride.
Precious Metals and Cannabis Could Surprise to the Upside in 2022
And there are a few ETFs and a silver miner that could provide the vehicles to play this hunch.
With BAD and VICE ETFs, the Devil Is in the Details
Will these exchange-traded funds pay off or send your portfolio up in a 'PUF'?
We Have Thin and Random Trading But an Upbeat Bias
We're in good shape for a continuation of the upside action next week.
Here's the Level I'm Focused on With Village Farms
Today's move has a good shot at breaking the nasty downtrend from the past three weeks.
Let's Unroll Two Cannabis-Related ETFs
Let's review Advisor Shares Pure Cannabis and Amplify Seymour Cannabis ETFs -- and what do swaps have to do with the 'sticky icky.'